Santosh Devidas Diwakar

Title: Innovator Spotlight: Santosh Devidas Diwakar

Introduction

Santosh Devidas Diwakar, located in Ahmedabad, India, is an accomplished inventor with two notable patents to his name. His innovative contributions primarily focus on pharmaceuticals, specifically in formulations that enhance the efficacy of important medications.

Latest Patents

Diwakar's latest patents include a process for the preparation of apixaban - a crystalline form N-1 of apixaban, which is substantially free from certain chemical compounds, and an amorphous form of apremilast. The first patent details the preparation of apixaban with a mean particle size equal to or greater than 100 µm, aiming to improve drug delivery and performance. The second patent presents an amorphous form of apremilast along with a pharmaceutical composition designed for the treatment of active psoriatic arthritis, significantly contributing to the therapeutic options available for this condition.

Career Highlights

Currently, Santosh Devidas Diwakar is associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work there has allowed him to push the boundaries of pharmaceutical formulation, leading to advancements that benefit patients in need of more effective treatment options.

Collaborations

Throughout his career, Diwakar has collaborated with colleagues such as Brij Khera and Kumar Kamlesh Singh. These partnerships have facilitated a shared exchange of ideas and expertise, driving innovation within his field and enhancing the impact of their collective work in pharmaceutical development.

Conclusion

Santosh Devidas Diwakar exemplifies the spirit of innovation through his dedication to advancing pharmaceutical formulations. With his patents addressing critical medical needs, he continues to be an influential figure in the industry, contributing substantially to healthcare advancements.